|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 137.44 USD | -0.15% |
|
-0.30% | -3.10% |
| 12/02 | Neurocrine Biosciences, Inc., Q4 2025 Earnings Call, Feb 11, 2026 | |
| 12/02 | Neurocrine Biosciences Fiscal Q4 Adjusted Earnings, Revenue Rise; Sets INGREZZA FY Guidance | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 27.7x | 4.22x | 0.55x | 4.26x | 18.97x | 19.41x | -.--% | 1.37TCr | ||
| 45.03x | 34x | 0.49x | 14.66x | 32.51x | 35.36x | 0.58% | 91TCr | ||
| 21.88x | 7.41x | 0.24x | 6.45x | 17.93x | 19.67x | 2.14% | 58TCr | ||
| 61.68x | 21158.05x | 1.24x | 7.33x | 18.16x | 18.69x | 2.96% | 39TCr | ||
| 18.46x | 6.45x | 0.9x | 4.66x | 11.57x | 13.08x | 2.82% | 37TCr | ||
| 21.04x | 6.45x | 4.06x | 5.88x | 14.48x | 15.41x | 2.75% | 30TCr | ||
| 31.88x | 7.03x | 0.78x | 5.72x | 17.06x | 17.83x | 1.61% | 31TCr | ||
| 15.41x | 5.38x | 1.03x | 4.95x | 10.8x | 11.99x | 2.71% | 30TCr | ||
| 14.71x | 6.24x | -1.56x | 5.03x | 10.56x | 12.31x | 3.54% | 22TCr | ||
| 28.48x | 21.82x | 0.41x | 6.66x | 11.4x | 15.3x | 2.61% | 20TCr | ||
| 22.85x | 8.58x | 0.01x | 7.06x | 12.91x | 15.6x | 2.13% | 19TCr | ||
| 13.52x | 1.74x | 0.3x | 3.25x | 8.05x | 9.49x | 6.17% | 16TCr | ||
| 14.91x | 6.23x | -0.08x | 3.25x | 10.12x | 10.68x | 4.11% | 12TCr | ||
| 15.48x | 6x | 0.13x | 3.09x | 8.94x | 10.41x | 3.01% | 12TCr | ||
| 12.3x | 1.29x | 0.27x | 2.57x | 8.4x | 9.27x | 4.98% | 12TCr | ||
| 29.77x | 6.16x | -0.04x | 8.95x | 19.18x | 20.04x | -.--% | 12TCr | ||
| 34.69x | 7.5x | 3.31x | 11.19x | 21.99x | 23.44x | 2.81% | 9.68TCr | ||
| 51.1x | 1.28x | 0.86x | 2.85x | 10.83x | 30.38x | 3.58% | 5.75TCr | ||
| 44.78x | 6.38x | 1.42x | 10.65x | 35.38x | 36.93x | 0.47% | 5.65TCr | ||
| 142.46x | 1.38x | -1.27x | 1.69x | 8.11x | 13.99x | 0.24% | 5.38TCr | ||
| Average | 33.41x | 1,065.18x | 0.65x | 6.01x | 15.37x | 17.96x | 2.46% | 23.41TCr | |
| Weighted average by Cap. | 31.25x | 1,775.93x | 0.73x | 7.50x | 17.84x | 19.82x | 2.29% |
- Stock Market
- Equities
- NBIX Stock
- Sector Neurocrine Biosciences, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















